Preclinical evaluation and validation of [F-18]HX4, a promising hypoxia marker for PET imaging

Ludwig J. Dubois*, Natasja G. Lieuwes, Marco H. M. Janssen, Wenny J. M. Peeters, Albert D. Windhorst, Joseph C. Walsh, Hartmuth C. Kolb, Michel C. Ollers, Johan Bussink, Guus A. M. S. van Dongen, Albert J. van der Kogel, Philippe Lambin

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

105 Citations (Web of Science)
17 Downloads (Pure)

Abstract

Hypoxia has been shown to be an important microenvironmental parameter influencing tumor progression and treatment efficacy. Patient guidance for hypoxia-targeted therapy requires evaluation of tumor oxygenation, preferably in a noninvasive manner. The aim of this study was to evaluate and validate the uptake of [F-18] HX4, a novel developed hypoxia marker for PET imaging. A heterogeneous accumulation of [F-18] HX4 was found within rat rhabdomyosarcoma tumors that was significantly (P <0.0001) higher compared with the surrounding tissues, with temporal increasing tumor-to-blood ratios reaching a plateau of 7.638 +/- 0.926 and optimal imaging properties 4 h after injection. [F-18] HX4 retention in normal tissues was found to be short-lived, homogeneous and characterized by a fast progressive temporal clearance. Heterogeneity in [F-18] HX4 tumor uptake was analyzed based on 16 regions within the tumor according to the different orthogonal planes at the largest diameter. Validation of heterogeneous [F-18] HX4 tumor uptake was shown by a strong and significant relationship (r = 0.722; P <0.0001) with the hypoxic fraction as calculated by the percentage pimonidazole-positive pixels. Furthermore, a causal relationship with tumor oxygenation was established, because combination treatment of nicotinamide and carbogen resulted in a 40% reduction (P <0.001) in [F-18] HX4 tumor accumulation whereas treatment with 7% oxygen breathing resulted in a 30% increased uptake (P <0.05). [F-18] HX4 is therefore a promising candidate for noninvasive detection and evaluation of tumor hypoxia at a macroscopic level.
Original languageEnglish
Pages (from-to)14620-14625
JournalProceedings of the National Academy of Sciences of the United States of America
Volume108
Issue number35
DOIs
Publication statusPublished - 30 Aug 2011

Keywords

  • cancer
  • nuclear medicine
  • experimental research

Cite this